# MTCP1

## Overview
The MTCP1 gene encodes proteins that play a significant role in the regulation of cell cycle and apoptosis, particularly within T cells. It produces two main protein isoforms, p13 MTCP1 and p8 MTCP1, through alternative splicing. The p13 MTCP1 protein is characterized by a compact eight-stranded β-barrel structure, which is similar to the oncogenic protein p14 TCL1, suggesting its involvement in oncogenic processes (Barthe1997Solution; Fu1998Crystal). Meanwhile, the p8 MTCP1 protein is distinguished by its α-antiparallel helical hairpin motif, stabilized by disulfide bridges, and is localized in mitochondria (Barthe1997Solution). MTCP1 is notably implicated in T-cell prolymphocytic leukemia (T-PLL) due to its involvement in chromosomal translocations that lead to its dysregulated expression, thereby contributing to leukemogenesis (Chun2002TCL‐1). Despite its recognized role in certain leukemias, the precise biological functions of MTCP1 in normal cellular processes remain to be fully elucidated.

## Structure
The MTCP1 gene encodes proteins with distinct structural features, primarily p13 MTCP1 and p8 MTCP1, resulting from different splicing forms. The p13 MTCP1 protein is characterized by a compact eight-stranded β-barrel structure, which is tightly packed and hydrophobic, with no large cavities. This β-barrel is composed of a long β-sheet on one side and a shorter β-sheet on the other, connected by a long loop, contributing to its unique topology and slow folding rate (Fu1998Crystal; Roumestand2001Characterization). The p8 MTCP1 protein, on the other hand, features a unique α-antiparallel helical hairpin motif stabilized by disulfide bridges, which is unusual for α-helical structures. This motif is stabilized by interchain hydrophobic interactions, forming a hydrophobic core with helix III (Barthe1997Solution).

The p8 MTCP1 protein is cysteine-rich and localized in mitochondria, with a three-dimensional structure consisting of three α-helices. Two of these helices form an α-hairpin with disulfide bridges, resembling an antiparallel coiled-coil, while the third helix is less defined (Barthe1999Refinedsolutionstructureandbackbonedynamicsof15NlabeledC12Ap8MTCPstudiedbyNMRrelaxation). The arrangement of cysteine residues in p8 MTCP1 leads to a favorable geometry for disulfide bridges, contributing to the protein's stability (Barthe1997Solution).

## Function
The MTCP1 gene encodes proteins that are involved in cell cycle regulation and apoptosis, primarily expressed in T cells. It has two major splicing forms, A and B, which encode the proteins p13 MTCP1 and p8 MTCP1, respectively. The p13 MTCP1 protein is similar to p14 TCL1, suggesting a new family of oncogenic proteins (Barthe1997Solution). The p8 MTCP1 protein is rich in cysteine residues and is localized in mitochondria, where it is expressed at low levels in most human tissues but overexpressed in proliferating T cells. This suggests a role in cell proliferation and a potential involvement in oncogenesis (Barthe1997Solution).

The MTCP1 protein folds into a compact eight-stranded antiparallel β-barrel with a short helix, a structure that is unique compared to other known protein families (Fu1998Crystal). The protein's structure includes a novel α-helical assembly motif, characterized by two antiparallel α-helices stabilized by disulfide bridges and hydrophobic contacts (Barthe1997Solution). Despite these structural insights, the exact biological function of MTCP1 in healthy human cells remains unknown, though its overexpression in certain T-cells suggests a role in cell proliferation (Barthe1997Solution).

## Clinical Significance
MTCP1 is implicated in the pathogenesis of T-cell prolymphocytic leukemia (T-PLL), a rare and aggressive form of leukemia. This gene is often involved in chromosomal translocations, such as t(X;14)(q28;q11), which lead to its dysregulated expression and contribute to leukemogenesis (Teitell2005The; Chun2002TCL‐1). In T-PLL, MTCP1 overexpression is associated with chromosomal rearrangements that disrupt normal cell proliferation and survival pathways, particularly through interactions with the AKT signaling pathway (Teitell2005The). 

MTCP1's role in cancer is linked to its ability to bind and activate AKT proteins, which are crucial for cell growth and survival. Although MTCP1's interaction with AKT is weaker compared to other TCL1 family members, it still contributes to the transformation of lymphocytes, potentially leading to malignancies (Teitell2005The). 

In some cases of mature T-cell leukemia, MTCP1 rearrangements are absent, suggesting alternative oncogenic pathways may be involved. These cases share clinical features with T-PLL but lack the defining MTCP1 rearrangements, indicating a possible distinct subtype or entity within T-cell leukemias (Fang2023Mature).

## Interactions
The MTCP1 gene encodes the p13 MTCP1 protein, which is implicated in certain T-cell leukemias due to chromosomal rearrangements. While direct evidence of specific interactions between p13 MTCP1 and other proteins is limited, the protein is suggested to act as a potential co-activator of AKT kinases, which are involved in major signal transduction pathways (Kitahara2002Equilibrium). This implies that p13 MTCP1 may participate in interactions that influence cell signaling, although the exact nature of these interactions remains to be fully elucidated.

The structural analysis of p13 MTCP1 reveals a compact eight-stranded β-barrel structure, which is similar to that of p14 TCL1, suggesting potential analogous functions and interactions with similar protein partners (Guignard2000Backbonedynamicsandsolutionstructurerefinementofthe15Nlabeledhumanoncogenicproteinp13MTCP1:ComparisonwithXraydata). Despite these structural insights, specific binding partners or interaction mechanisms have not been detailed in the available literature.

The p8 MTCP1 protein, another product of the MTCP1 gene, is rich in cysteine residues and localized in mitochondria, where it is overexpressed in proliferating T cells. This suggests a potential role in oncogenesis, although specific interactions with other proteins or nucleic acids have not been described (Barthe1997Solution).


## References


[1. (Teitell2005The) Michael A. Teitell. The tcl1 family of oncoproteins: co-activators of transformation. Nature Reviews Cancer, 5(8):640–648, August 2005. URL: http://dx.doi.org/10.1038/nrc1672, doi:10.1038/nrc1672. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/nrc1672)

[2. (Barthe1999Refinedsolutionstructureandbackbonedynamicsof15NlabeledC12Ap8MTCPstudiedbyNMRrelaxation) Philippe Barthe, Laurent Chiche, Nathalie Declerck, Marc-André Delsuc, Jean-François Lefèvre, Thérèse Malliavin, Joel Mispelter, Marc-Henri Stern, Jean-Marc Lhoste, and Christian Roumestand. Refined solution structure and backbone dynamics of 15n-labeled c12a-p8mtcp studied by nmr relaxation. Journal of Biomolecular NMR, 15(4):271–288, 1999. URL: http://dx.doi.org/10.1023/A:1008336418418, doi:10.1023/a:1008336418418. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1023/A:1008336418418)

[3. (Fu1998Crystal) Zheng-Qing Fu, Garrett C. Du Bois, Sherry P. Song, Irina Kulikovskaya, Laura Virgilio, Jay L. Rothstein, Carlo M. Croce, Irene T. Weber, and Robert W. Harrison. Crystal structure of mtcp-1: implications for role of tcl-1 and mtcp-1 in t cell malignancies. Proceedings of the National Academy of Sciences, 95(7):3413–3418, March 1998. URL: http://dx.doi.org/10.1073/pnas.95.7.3413, doi:10.1073/pnas.95.7.3413. This article has 27 citations.](https://doi.org/10.1073/pnas.95.7.3413)

[4. (Chun2002TCL‐1) Helen H. Chun, Sergi Castellví‐Bel, Zhijun Wang, Robert A. Nagourney, Susan Plaeger, Sara G. Becker‐Catania, Faramarz Naeim, Robert S. Sparkes, and Richard A. Gatti. Tcl‐1, mtcp‐1 and tml‐1 gene expression profile in non‐leukemic clonal proliferations associated with ataxia‐telangiectasia. International Journal of Cancer, 97(6):726–731, January 2002. URL: http://dx.doi.org/10.1002/ijc.10102, doi:10.1002/ijc.10102. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.10102)

[5. (Kitahara2002Equilibrium) Ryo Kitahara, Catherine Royer, Hiroaki Yamada, Mireille Boyer, Jean-Louis Saldana, Kazuyuki Akasaka, and Christian Roumestand. Equilibrium and pressure-jump relaxation studies of the conformational transitions of p13mtcp1. Journal of Molecular Biology, 320(3):609–628, July 2002. URL: http://dx.doi.org/10.1016/S0022-2836(02)00516-8, doi:10.1016/s0022-2836(02)00516-8. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/S0022-2836(02)00516-8)

[6. (Barthe1997Solution) Philippe Barthe, Yin-Shan Yang, Laurent Chiche, François Hoh, Marie-Paule Strub, Laurent Guignard, Jean Soulier, Marc-Henri Stern, Herman van Tilbeurgh, Jean-Marc Lhoste, and Christian Roumestand. Solution structure of human p8mtcp1, a cysteine-rich protein encoded by the mtcp1 oncogene, reveals a new α-helical assembly motif. Journal of Molecular Biology, 274(5):801–815, December 1997. URL: http://dx.doi.org/10.1006/jmbi.1997.1438, doi:10.1006/jmbi.1997.1438. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1006/jmbi.1997.1438)

[7. (Guignard2000Backbonedynamicsandsolutionstructurerefinementofthe15Nlabeledhumanoncogenicproteinp13MTCP1:ComparisonwithXraydata) Laurent Guignard, André Padilla, Joel Mispelter, Yin-Shan Yang, Marc-Henri Stern, Jean-Marc Lhoste, and Christian Roumestand. Backbone dynamics and solution structure refinement of the 15n-labeled human oncogenic protein p13mtcp1: comparison with x-ray data. Journal of Biomolecular NMR, 17(3):215–230, 2000. URL: http://dx.doi.org/10.1023/A:1008386110930, doi:10.1023/a:1008386110930. This article has 31 citations and is from a peer-reviewed journal.](https://doi.org/10.1023/A:1008386110930)

[8. (Roumestand2001Characterization) Christian Roumestand, Mireille Boyer, Laurent Guignard, Philippe Barthe, and Catherine A. Royer. Characterization of the folding and unfolding reactions of a small β-barrel protein of novel topology, the mtcp1 oncogene product p13 1 1edited by c. r. matthews. Journal of Molecular Biology, 312(1):247–259, September 2001. URL: http://dx.doi.org/10.1006/jmbi.2001.4928, doi:10.1006/jmbi.2001.4928. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1006/jmbi.2001.4928)

9. (Fang2023Mature) Mature T-cell Leukemia Primarily Involving Blood and Bone Marrow without TCL1 or MTCP1 Rearrangement: A Subtype of T-Prolymphocytic Leukemia or a Distinct Entity?. This article has 0 citations.